229 related articles for article (PubMed ID: 27644242)
21. A comparative study of efficacy and safety of febuxostat and allopurinol in pyrazinamide-induced hyperuricemic tubercular patients.
Pichholiya M; Yadav AK; Luhadia SK; Tahashildar J; Aseri ML
Indian J Pharmacol; 2016; 48(5):522-525. PubMed ID: 27721537
[TBL] [Abstract][Full Text] [Related]
22. Single blind, multicentre, randomized, controlled trial testing the effects of a novel nutraceutical compound on plasma lipid and cardiovascular risk factors: Results of the interim analysis.
Trimarco V; Battistoni A; Tocci G; Coluccia R; Manzi MV; Izzo R; Volpe M
Nutr Metab Cardiovasc Dis; 2017 Oct; 27(10):850-857. PubMed ID: 28965797
[TBL] [Abstract][Full Text] [Related]
23. Effective uric acid-lowering treatment for hypertensive patients with hyperuricemia.
Ohta Y; Ishizuka A; Arima H; Hayashi S; Iwashima Y; Kishida M; Yoshihara F; Nakamura S; Kawano Y
Hypertens Res; 2017 Mar; 40(3):259-263. PubMed ID: 27760998
[TBL] [Abstract][Full Text] [Related]
24. Mild Hyperuricemia: To Treat, or Not to Treat, That is the Question. Suggestions form the URRAH Study.
Semplicini A
High Blood Press Cardiovasc Prev; 2020 Apr; 27(2):119-120. PubMed ID: 32207069
[No Abstract] [Full Text] [Related]
25. Flavonoids and phenylethanoid glycosides from Lippia nodiflora as promising antihyperuricemic agents and elucidation of their mechanism of action.
Cheng LC; Murugaiyah V; Chan KL
J Ethnopharmacol; 2015 Dec; 176():485-93. PubMed ID: 26593216
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial.
Sircar D; Chatterjee S; Waikhom R; Golay V; Raychaudhury A; Chatterjee S; Pandey R
Am J Kidney Dis; 2015 Dec; 66(6):945-50. PubMed ID: 26233732
[TBL] [Abstract][Full Text] [Related]
27. Allopurinol Against Progression of Chronic Kidney Disease.
Golmohammadi S; Almasi A; Manouchehri M; Omrani HR; Zandkarimi MR
Iran J Kidney Dis; 2017 Jul; 11(4):286-293. PubMed ID: 28794291
[TBL] [Abstract][Full Text] [Related]
28. Placebo-controlled, double-blind study of the non-purine-selective xanthine oxidase inhibitor Febuxostat (TMX-67) in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S19-26. PubMed ID: 21654266
[TBL] [Abstract][Full Text] [Related]
29. Prednisone in Uric Acid lowering in Symptomatic Heart Failure Patients With Hyperuricemia (PUSH-PATH) study.
Liu C; Zhao Q; Zhen Y; Gao Y; Tian L; Wang L; Ji L; Liu G; Ji Z; Liu K
Can J Cardiol; 2013 Sep; 29(9):1048-54. PubMed ID: 23395281
[TBL] [Abstract][Full Text] [Related]
30. The effects of lowering uric acid levels using allopurinol on markers of metabolic syndrome in end-stage renal disease patients: a pilot study.
Shelmadine B; Bowden RG; Wilson RL; Beavers D; Hartman J
Anadolu Kardiyol Derg; 2009 Oct; 9(5):385-9. PubMed ID: 19819789
[TBL] [Abstract][Full Text] [Related]
31. Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic Hyperuricemia.
Takir M; Kostek O; Ozkok A; Elcioglu OC; Bakan A; Erek A; Mutlu HH; Telci O; Semerci A; Odabas AR; Afsar B; Smits G; ALanaspa M; Sharma S; Johnson RJ; Kanbay M
J Investig Med; 2015 Dec; 63(8):924-9. PubMed ID: 26571421
[TBL] [Abstract][Full Text] [Related]
32. An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 2 exploratory clinical study.
Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S44-9. PubMed ID: 21654269
[TBL] [Abstract][Full Text] [Related]
33. [Hyperuricemia and gout: diagnosis and therapy].
Tausche AK; Unger S; Richter K; Wunderlich C; Grässler J; Roch B; Schröder HE
Internist (Berl); 2006 May; 47(5):509-20; quiz 521. PubMed ID: 16586130
[TBL] [Abstract][Full Text] [Related]
34. Uric acid levels and the risk of Contrast Induced Nephropathy in patients undergoing coronary angiography or PCI.
Barbieri L; Verdoia M; Schaffer A; Cassetti E; Marino P; Suryapranata H; De Luca G;
Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):181-6. PubMed ID: 25315668
[TBL] [Abstract][Full Text] [Related]
35. An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S13-8. PubMed ID: 21654265
[TBL] [Abstract][Full Text] [Related]
36. Green tea polyphenols decreases uric acid level through xanthine oxidase and renal urate transporters in hyperuricemic mice.
Chen G; Tan ML; Li KK; Leung PC; Ko CH
J Ethnopharmacol; 2015 Dec; 175():14-20. PubMed ID: 26344851
[TBL] [Abstract][Full Text] [Related]
37. Why better treatment of gout is needed.
So AK
Clin Exp Rheumatol; 2016; 34(4 Suppl 98):63-5. PubMed ID: 27586807
[TBL] [Abstract][Full Text] [Related]
38. Oral uricase eliminates blood uric acid in the hyperuricemic pig model.
Szczurek P; Mosiichuk N; Woliński J; Yatsenko T; Grujic D; Lozinska L; Pieszka M; Święch E; Pierzynowski SG; Goncharova K
PLoS One; 2017; 12(6):e0179195. PubMed ID: 28594873
[TBL] [Abstract][Full Text] [Related]
39. Antioxidative phytochemicals from Rhododendron oldhamii Maxim. leaf extracts reduce serum uric acid levels in potassium oxonate-induced hyperuricemic mice.
Tung YT; Lin LC; Liu YL; Ho ST; Lin CY; Chuang HL; Chiu CC; Huang CC; Wu JH
BMC Complement Altern Med; 2015 Dec; 15():423. PubMed ID: 26627882
[TBL] [Abstract][Full Text] [Related]
40. Serum Uric Acid-Lowering Effects of Combined Glycine and Tryptophan Treatments in Subjects with Mild Hyperuricemia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
Oshima S; Shiiya S; Nakamura Y
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30845731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]